Participants who followed the full escalation schedule tolerated the compound significantly better than those in earlier trials where escalation was faster
Nine of the 29 evaluable patients exhibit disease stability, with a median progression-free survival (PFS) of 5.0 months And a median OS of 10.8 months in the phase IIa group
MarketBeat Week in Review 11/4 - 11/8 Altimmune (NASDAQ:ALT) management used an appearance at the Goldman Sachs Global Healthcare Conference to outline the company's focus on pemvidutide, its lead metabolic and liver disease drug candidate, and to discuss the planned Phase 3 program in metabolic dysfunction-associated steatohepatitis, or MASH
About Us Ready to feel like yourself again just lighter, brighter, and full of energy
Typically, we aim for a BMI below 30 or within 20 pounds of your goal weight before planning body contouring procedures
Dose Increases Each dose escalation triggers a new adjustment phase